How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Sell
17
VERA Quote, Financials, Valuation and Earnings
Last price:
$42.52
Seasonality move
:
32.34%
Day range:
$41.20 - $43.12
52-week range:
$14.20 - $51.61
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
9.31x
Volume:
158.6K
Avg. volume:
563.1K
1-year change:
164.48%
Market cap:
$2.7B
Revenue:
--
EPS (TTM):
-$2.61
Analysts' Opinion
-
Consensus RatingVera Therapeutics has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Vera Therapeutics has an estimated upside of 54.06% from its current price of $41.92.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $41.92.
Fair Value
-
According to the consensus of 0 analysts, Vera Therapeutics has 54.06% upside to fair value with a price target of -- per share.
VERA vs. S&P 500
-
Over the past 5 trading days, Vera Therapeutics has underperformed the S&P 500 by -7.27% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Vera Therapeutics does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Vera Therapeutics has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Vera Therapeutics reported revenues of --.
Earnings Growth
-
Vera Therapeutics has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Vera Therapeutics reported earnings per share of -$0.85.
Enterprise value:
2.4B
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-19.44x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -$73.9M | -$108.6M | -$145.3M | -$21.8M | -$49.8M | |
| EBITDA | -$73M | -$98.9M | -$126M | -$19.2M | -$44.7M | |
| Diluted EPS | -$2.96 | -$2.90 | -$2.61 | -$0.45 | -$0.85 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $89.8M | $125M | $171.6M | $364.1M | |
| Total Assets | -- | $91.2M | $131.4M | $175.6M | $368.6M | |
| Current Liabilities | -- | $4M | $15.9M | $24.6M | $26.5M | |
| Total Liabilities | -- | $5.7M | $25.7M | $51.9M | $79.5M | |
| Total Equity | -- | $85.5M | $105.7M | $123.7M | $289.1M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$52.9M | -$88.2M | -$120.6M | -$23M | -$36.9M | |
| Cash From Investing | -$89M | -$44.6M | -$185.1M | $16.2M | $38.3M | |
| Cash From Financing | $86.1M | $129.4M | $305.5M | $297K | $739K | |
| Free Cash Flow | -$52.9M | -$88.2M | -$121M | -$23M | -$37.1M | |
VERA
Sector
Market Cap
$2.7B
$46.1M
Price % of 52-Week High
82.38%
46.02%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.6%
1-Year Price Total Return
164.48%
-30.52%
Beta (5-Year)
--
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$42.77
200-day SMA
Buy
Level
$40.77
Bollinger Bands (100)
Buy
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$45.96
Relative Strength Index (RSI14)
Sell
Level
35.55
ADX Line
Neutral
Level
0
Williams %R
Buy
Level
-86.8772
50-day SMA
Sell
Level
$45.14
MACD (12, 26)
Sell
Level
-1.16
25-day Aroon Oscillator
Sell
Level
-52
On Balance Volume
Neutral
Level
--
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Stock Forecast FAQ
In the current month, VERA has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The VERA average analyst price target in the past 3 months is --.
-
Where Will Vera Therapeutics Stock Be In 1 Year?
According to analysts, the consensus estimate is that Vera Therapeutics share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Vera Therapeutics?
Analysts are divided on their view about Vera Therapeutics share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Vera Therapeutics is a Sell and believe this share price will drop from its current level to --.
-
What Is Vera Therapeutics's Price Target?
The price target for Vera Therapeutics over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is VERA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Vera Therapeutics is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of VERA?
You can purchase shares of Vera Therapeutics via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Vera Therapeutics shares.
-
What Is The Vera Therapeutics Share Price Today?
Vera Therapeutics was last trading at $42.52 per share. This represents the most recent stock quote for Vera Therapeutics. Yesterday, Vera Therapeutics closed at $41.92 per share.
-
How To Buy Vera Therapeutics Stock Online?
In order to purchase Vera Therapeutics stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
60
QMCO alert for Dec 26
Quantum [QMCO] is up 49.62% over the past day.
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is up 49.85% over the past day.
Buy
65
TSLL alert for Dec 26
Direxion Daily TSLA Bull 2X Shares [TSLL] is down 3.73% over the past day.
